IRIS BioTechnologies Revenue and Competitors
Estimated Revenue & Valuation
- IRIS BioTechnologies's estimated annual revenue is currently $1.1M per year.
- IRIS BioTechnologies's estimated revenue per employee is $155,000
Employee Data
- IRIS BioTechnologies has 7 Employees.
- IRIS BioTechnologies grew their employee count by 0% last year.
IRIS BioTechnologies's People
| Name | Title | Email/Phone |
|---|
IRIS BioTechnologies Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $81.4M | 375 | 40% | N/A | N/A |
#2 | $16.9M | 109 | 22% | N/A | N/A |
#3 | $156.1M | 120 | -70% | $145M | N/A |
#4 | $2.9M | 37 | -24% | $150M | N/A |
#5 | $1.3M | 17 | 0% | $459.5M | N/A |
#6 | $49.2M | 254 | 15% | $180.7M | N/A |
#7 | $7M | 45 | -2% | N/A | N/A |
#8 | $256.3M | 840 | 9% | $168.5M | N/A |
#9 | $10.1M | 65 | 5% | N/A | N/A |
#10 | $16.1M | 104 | 9% | N/A | N/A |
What Is IRIS BioTechnologies?
Iris BioTechnologies has been perfecting the 21st Century tools necessary to bring P4 medicine to the clinic. Iris’s state-of-the-art Nano-biochips™ and BioWindows™ medical informatics system are capable of capturing and analyzing the many alterations in cancer pathways by capturing mRNA, microRNA, proteins or other biomarkers. Our patented products were developed to overcome the sensitivity, specificity, speed and cost limitations of present state-of-the-art microarray technology. The Iris products are designed to be FDA approved, enabling them to be used in any certified laboratory in the United States.
keywords:N/A
N/A
Total Funding
7
Number of Employees
$1.1M
Revenue (est)
0%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Other Companies in
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $0.1M | 7 | 0% | $36M |
#2 | $0.9M | 7 | 0% | N/A |
#3 | $0.1M | 7 | 0% | $6.1M |
#4 | $0.1M | 7 | -12% | $12M |
#5 | $3.5M | 7 | -30% | N/A |